Category: Symptoms
UK: 1 in 20 secondary school pupils have experienced Long Covid
A new UK ONS survey out today reveals the horrifying extent of Covid damage to Britain’s school kids, with one in twenty secondary school pupils and one in fifty primary school pupils experiencing Long Covid. More...
Monkeypox research: 50% household attack rate
2016 research: “The household attack rate (i.e., rate of persons living with an infected person that develop symptoms of MPXV infection) was 50%.” More...
Preprint: Long COVID-19 liver manifestation in children
“We report two distinct patterns of potentially long COVID-19 liver manifestations in children with common clinical, radiological, and histopathological characteristics after a thorough workup excluded other known etiologies.” More...
UKHSA: Monkeypox Technical Briefing 1 published
The UK Health and Security Agency has published its first technical briefing for the Monkeypox outbreak in England. More...
Monkeypox: “We don’t know the efficacy of any of these monkeypox vaccines”
“How well MVA really protects humans from monkeypox is uncertain. More...
UK: 18 more children diagnosed with sudden onset hepatitis, total now 240
“Active investigations have identified a further 18 confirmed cases since the last update on 27 May, bringing the total number of cases in the UK to 240, as of 7 June.” More...
UK: Monkeypox is a notifiable disease from 8 June 2022
Monkeypox is to be listed as a notifiable disease in law in the UK from 8 June 2022. More...
WHO: Monkeypox may be airborne
In its latest Monkeypox update, the World Health Organisation’s has declared, for the first time, that Monkeypox may be airborne. More...
SARS-CoV-2 Infection and Persistence Throughout the Human Body and Brain
A video presentation of the recent study entitled “SARS-CoV-2 Infection and Persistence Throughout the Human Body and Brain”. More...
Preprint: COVID-19 vaccination and Guillain-Barré syndrome
“Our study reports an association between first-dose ChAdOx1 nCoV-19 (AstraZeneca) COVID-19 vaccination and Guillain-Barré syndrome, accounting for an estimated excess incidence of 5.8 Guillain-Barré syndrome cases per million first doses.” More...